whether a DOUBLE dose of clopidogrel (Plavix) prevents more cardiovascular events in stent patients

Experts are debating whether a DOUBLE dose of clopidogrel (Plavix) prevents more cardiovascular events in stent patients.

Up to 25% of patients don't respond well to clopidogrel's antiplatelet effects...and are at higher risk for a cardiac event.

So some prescribers order platelet function tests to identify patients who have high platelet activity despite clopidogrel therapy.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote